4//SEC Filing
Cartt Stephen LaHue 4
Accession 0001140361-18-029804
CIK 0001572552other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:42 PM ET
Size
8.2 KB
Accession
0001140361-18-029804
Insider Transaction Report
Form 4
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
- Award
Stock Options
2018-06-21+20,000→ 20,000 totalExercise: $1.75Exp: 2028-06-21→ Common Stock (20,000 underlying)
Holdings
- 375,000
Stock Options
Exercise: $3.64Exp: 2026-02-28→ Common Stock (375,000 underlying) - 292,783
Common Stock
- 20,000
Stock Options
Exercise: $3.70Exp: 2027-06-26→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The stock options vest equally over the next four quarters, beginning on the June 30, 2018 contingent upon continued service on the Board of Directors.
- [F2]Subject to Mr. Cartt's continued service on the Board of the Company, the stock options over four equal quarterly installments beginning on July 1, 2017. The stock options are exercisable upon vesting.
- [F3]The stock options vested and are exercisable.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeother
Related Parties
1- filerCIK 0001321073
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:42 PM ET
- Size
- 8.2 KB